DRUG
DRUG
NASDAQ · Biotechnology

Bright Minds Biosciences Inc

$80.00
+2.65 (+3.43%)
As of Aug 8, 1:43 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -66.3% upside
Low Target $16.82
Average Target $26.95
High Target $32.06
Current Price $80.00
Current
$80.00
Target
$26.95
$16.82 $26.95 avg $32.06
Scenario Analysis
Bear Case
$16.82
-79.0%
Low target
Base Case
$26.95
-66.3%
Avg target
Bull Case
$32.06
+-59.9%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$170.00
-52.9% from high
52-Week Low
$50.50
+58.4% from low
Target vs 52W High
$26.95
-84.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%